Axonics Revenue and Competitors
Estimated Revenue & Valuation
- Axonics's estimated annual revenue is currently $161.9M per year.
- Axonics's estimated revenue per employee is $220,327
- Axonics's current valuation is $2.5B. (January 2022)
Employee Data
- Axonics has 735 Employees.
- Axonics grew their employee count by 22% last year.
Axonics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | General Counsel & Chief Compliance Officer | Reveal Email/Phone |
3 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
4 | SVP General/IP Counsel/I&p | Reveal Email/Phone |
5 | VP, Strategic Initiatives | Reveal Email/Phone |
6 | VP, Market Growth | Reveal Email/Phone |
7 | VP, Quality | Reveal Email/Phone |
8 | VP, Regulatory Affairs | Reveal Email/Phone |
9 | VP, Manufacturing Business Operations | Reveal Email/Phone |
10 | Director Training | Reveal Email/Phone |
Axonics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $31800M | 109578 | 4% | $367M | $146B |
What Is Axonics?
N/A
Total Funding
735
Number of Employees
$161.9M
Revenue (est)
22%
Employee Growth %
$2.5B
Valuation
N/A
Accelerator
Axonics News
2022-04-17 - Axonics kicks off US launch of long-lasting neurostim implant
Axonics kicks off U.S. launch of recharge-free sacral neuromodulation implant ... Barely a month after winning FDA clearance for its long-lasting...
2022-04-17 - Axonics® Announces Comprehensive Launch of the Axonics ...
Axonics® Announces Comprehensive Launch of the Axonics F15 Recharge-Free Sacral Neuromodulation System. Published: Apr 19, 2022. IRVINE, Calif.
2022-03-30 - Axonics® Launches Direct to Consumer Television ...
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $75M | 743 | 3% | N/A |
#2 | $267.1M | 751 | 6% | N/A |
#3 | $233.2M | 757 | N/A | N/A |
#4 | $111M | 776 | 0% | $66M |
#5 | $143.2M | 787 | -18% | N/A |